Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Imaging Biol ; 7(3): 236-43, 2005.
Article in English | MEDLINE | ID: mdl-15912428

ABSTRACT

PURPOSE: A retrospective analysis of the use of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) positron emission tomography (PET) was performed in patients with histologically proven disseminated carcinoma of unknown primary tumor (CUP). PROCEDURES: The records of 31 patients with CUP, excluding patients with isolated neck metastases, were reviewed to identify the ability of PET to detect the putative primary site (PPS) and/or to change therapeutic management. RESULTS: In eight out of 31 cases (26%), a PPS was confirmed, either definitively (one pathologically, one radiologically) (true positive) or clinically (six cases). For three cases (10%), histological evidence of a primary tumor distant from the PPS was found (false positive). In a further seven cases (23%), the PPS remained unconfirmed, whereas for 13 cases (42%) no PPS was identified. In five out of seven patients in whom the PET suggested a high probability of having identified the primary site, the PPS was confirmed definitively or clinically. PET altered clinical management in at least 12 cases (38%). CONCLUSIONS: PET contributed to the management of previously extensively investigated patients with CUP. Identification of a PPS and/or change in management was documented in 38% of cases, the majority of which were lung or pancreatic cancer. These findings are worthy of evaluation in a prospective study.


Subject(s)
Carcinoma/diagnosis , Fluorodeoxyglucose F18 , Neoplasms, Unknown Primary/diagnosis , Positron-Emission Tomography , Adult , Aged , Aged, 80 and over , Carcinoma/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasms, Unknown Primary/pathology , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...